Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Genomic islands and molecular mechanisms relating to drug-resistance in Clostridioides (Clostridium) difficile PCR ribotype 176

M. Krutova, V. Kovarovic, M. Brajerova, F. Demay, J. Zikova, S. Prasad, A. Soltesova, E. Novakova, H. Pituch, E. Kuijper, WK. Smits, GB. Novotna

. 2025 ; 14 (1) : 2482698. [pub] 20250409

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015082

OBJECTIVES: To analyse characteristics of Clostridioides difficile PCR ribotype 176 clinical isolates from Poland, the Czech Republic and Slovakia with regard to the differences in its epidemiology. METHODS: Antimicrobial susceptibility testing and whole genome sequencing were performed on a selected group of 22 clonally related isolates as determined by multilocus variable-number tandem repeat analysis (n = 509). Heterologous expression and functional analysis of the newly identified methyltransferase were performed. RESULTS: Core genome multilocus sequence typing found 10-37 allele differences. All isolates were resistant to fluoroquinolones (gyrA_p. T82I), aminoglycosides with aac(6')-Ie-aph(2'')-Ia in six isolates. Erythromycin resistance was detected in 21/22 isolates and 15 were also resistant to clindamycin with ermB gene. Fourteen isolates were resistant to rifampicin with rpoB_p. R505K or p. R505K/H502N, and five to imipenem with pbp1_p. P491L and pbp3_p. N537K. PnimBG together with nimB_p. L155I were detected in all isolates but only five were resistant to metronidazole on chocolate agar. The cfrE, vanZ1 and cat-like genes were not associated with linezolid, teicoplanin and chloramphenicol resistance, respectively. The genome comparison identified six transposons carrying antimicrobial resistance genes. The ermB gene was carried by new Tn7808, Tn6189 and Tn6218-like. The aac(6')-Ie-aph(2'')-Ia were carried by Tn6218-like and new Tn7806 together with cfrE gene. New Tn7807 carried a cat-like gene. Tn6110 and new Tn7806 contained an RlmN-type 23S rRNA methyltransferase, designated MrmA, associated with high-level macrolide resistance in isolates without ermB gene. CONCLUSIONS: Multidrug-resistant C. difficile PCR ribotype 176 isolates carry already described and unique transposons. A novel mechanism for erythromycin resistance in C. difficile was identified.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015082
003      
CZ-PrNML
005      
20250731090742.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/22221751.2025.2482698 $2 doi
035    __
$a (PubMed)40130321
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Krutova, Marcela $u Department of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic $u European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study group for Clostridioides difficile (ESGCD), Basel, Switzerland
245    10
$a Genomic islands and molecular mechanisms relating to drug-resistance in Clostridioides (Clostridium) difficile PCR ribotype 176 / $c M. Krutova, V. Kovarovic, M. Brajerova, F. Demay, J. Zikova, S. Prasad, A. Soltesova, E. Novakova, H. Pituch, E. Kuijper, WK. Smits, GB. Novotna
520    9_
$a OBJECTIVES: To analyse characteristics of Clostridioides difficile PCR ribotype 176 clinical isolates from Poland, the Czech Republic and Slovakia with regard to the differences in its epidemiology. METHODS: Antimicrobial susceptibility testing and whole genome sequencing were performed on a selected group of 22 clonally related isolates as determined by multilocus variable-number tandem repeat analysis (n = 509). Heterologous expression and functional analysis of the newly identified methyltransferase were performed. RESULTS: Core genome multilocus sequence typing found 10-37 allele differences. All isolates were resistant to fluoroquinolones (gyrA_p. T82I), aminoglycosides with aac(6')-Ie-aph(2'')-Ia in six isolates. Erythromycin resistance was detected in 21/22 isolates and 15 were also resistant to clindamycin with ermB gene. Fourteen isolates were resistant to rifampicin with rpoB_p. R505K or p. R505K/H502N, and five to imipenem with pbp1_p. P491L and pbp3_p. N537K. PnimBG together with nimB_p. L155I were detected in all isolates but only five were resistant to metronidazole on chocolate agar. The cfrE, vanZ1 and cat-like genes were not associated with linezolid, teicoplanin and chloramphenicol resistance, respectively. The genome comparison identified six transposons carrying antimicrobial resistance genes. The ermB gene was carried by new Tn7808, Tn6189 and Tn6218-like. The aac(6')-Ie-aph(2'')-Ia were carried by Tn6218-like and new Tn7806 together with cfrE gene. New Tn7807 carried a cat-like gene. Tn6110 and new Tn7806 contained an RlmN-type 23S rRNA methyltransferase, designated MrmA, associated with high-level macrolide resistance in isolates without ermB gene. CONCLUSIONS: Multidrug-resistant C. difficile PCR ribotype 176 isolates carry already described and unique transposons. A novel mechanism for erythromycin resistance in C. difficile was identified.
650    _2
$a lidé $7 D006801
650    12
$a antibakteriální látky $x farmakologie $7 D000900
650    12
$a Clostridioides difficile $x genetika $x účinky léků $x izolace a purifikace $x klasifikace $7 D016360
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    12
$a klostridiové infekce $x mikrobiologie $x epidemiologie $7 D003015
650    _2
$a ribotypizace $7 D021521
650    12
$a genomové ostrovy $7 D044404
650    _2
$a multilokusová sekvenční typizace $7 D058885
650    12
$a bakteriální léková rezistence $7 D024881
650    _2
$a methyltransferasy $x genetika $7 D008780
650    _2
$a sekvenování celého genomu $7 D000073336
650    _2
$a bakteriální proteiny $x genetika $7 D001426
650    12
$a mnohočetná bakteriální léková rezistence $x genetika $7 D024901
651    _2
$a Polsko $x epidemiologie $7 D011044
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kovarovic, Vojtech $u Institute of Microbiology, The Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
700    1_
$a Brajerova, Marie $u Department of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic $u European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study group for Clostridioides difficile (ESGCD), Basel, Switzerland
700    1_
$a Demay, Fanny $u Institute of Microbiology, The Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
700    1_
$a Zikova, Jaroslava $u Department of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
700    1_
$a Prasad, Suhanya $u Department of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
700    1_
$a Soltesova, Anna $u Department of Clinical Microbiology, Unilabs Slovakia Inc., Roznava, Slovakia
700    1_
$a Novakova, Elena $u Department of Microbiology and Immunology, Comenius University Jessenius Faculty of Medicine in Martin, Martin, Slovakia
700    1_
$a Pituch, Hanna $u Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland
700    1_
$a Kuijper, Ed $u European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study group for Clostridioides difficile (ESGCD), Basel, Switzerland $u Dutch National Expertise Centre for Clostridioides difficile infections, Leiden University Center for Infectious Diseases, Leiden and Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands $u Experimental Bacteriology, Leiden University Center for Infectious Diseases, Leiden Medical Center, Leiden, Netherlands
700    1_
$a Smits, Wiep Klaas $u European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study group for Clostridioides difficile (ESGCD), Basel, Switzerland $u Dutch National Expertise Centre for Clostridioides difficile infections, Leiden University Center for Infectious Diseases, Leiden and Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands $u Experimental Bacteriology, Leiden University Center for Infectious Diseases, Leiden Medical Center, Leiden, Netherlands
700    1_
$a Novotna, Gabriela Balikova $u Institute of Microbiology, The Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
773    0_
$w MED00190555 $t Emerging microbes & infections $x 2222-1751 $g Roč. 14, č. 1 (2025), s. 2482698
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40130321 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731090737 $b ABA008
999    __
$a ok $b bmc $g 2366147 $s 1252207
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 14 $c 1 $d 2482698 $e 20250409 $i 2222-1751 $m Emerging microbes & infections $n Emerg Microbes Infect $x MED00190555
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Možnosti archivace